期刊文献+

Alzheimer患者血清中含有低水平及低亲和力的抗Aβ自身抗体

Reduced low-affinity anti-β-amyloid autoantibodies in serum from Alzheimer's disease
下载PDF
导出
摘要 目的研究AD病人血清中Aβ自身抗体的特性及对老年斑的亲和力。方法选择AD、血管性痴呆(vascular dementia,VD)患者及正常老年人做为研究对象,采集血清标本,测定抗体含量,并亲和纯化抗体进行免疫组化染色。结果 AD患者血清中含有低水平的Aβ自身抗体,但抗体含量与性别、年龄和MMSE评分没有相关性;AD体内的抗体不能识别Tg2576鼠脑内的老年斑。结论 Aβ自身抗体的降低是AD病人特有的免疫低反应性所致;Aβ自身抗体与老年斑的亲和力明显降低;这些抗体的病理生理作用需要进一步研究。 Objective To investigate the characterization of anti-Aβ autoantibodies in AD patients and affinity ability of autoantibodies stainning the Aβplaques in vitro. Methods ELISA was performed to detect levels of naturally occuring anti-Aβautoantibodies in surum from AD patients, vascular dementia and age-macthed healthy controls.Immunohistochemistry assay was employed to confirm the affinity abillity of anti-Aβautoantibodies stainning the Aβ plaques in vitro. Results Naturally occuring anti-Aβautoantibodies in surum from AD patients was significantly lower than those from vascular dementia and healthy controls. The autiantibodies levels were independent of gender,age and MMSE scores in AD patients. Autoantibodies purified from healthy individuals and vascular dementia patients could readily stain the Aβplaques in transgenic mouse Tg2576, while those from AD patients could not. Conclusion Compared with vascular dementia and healthy controls, AD patients have obviously lower anti-Aβautoantibodies which could not stain Aβplaques in transgenic mouse and showed a low-affinity ability with Aβplaques in vitro. The petential pathophysiological function of autoantibodies in AD patients needs futher study.
出处 《分子影像学杂志》 2014年第3期140-142,共3页 Journal of Molecular Imaging
基金 广东省自然科学基金(7300973 S2012010009108) 广东省科技计划项(2010B031600167)
关键词 阿尔茨海默病 血管性痴呆 抗Aβ自身抗体 Alzheimer's disease Vascular dementia anti-Aβ autoantibody
  • 相关文献

参考文献18

  • 1马晋,段金海,邹俊涛,汪洋.人源化抗Aβ抗体治疗APP/PS1转基因鼠的实验研究[J].新医学,2014,45(2):95-98. 被引量:1
  • 2段金海,徐书雯,莫建伟,方运勇.人抗Aβ_(42)自身抗体的纯化及鉴定[J].解剖学研究,2011,33(3):172-175. 被引量:1
  • 3段金海,徐书雯,莫建伟,向绍通,方运勇,汪华侨,莫思杰,胡涛,姚志彬.Alzheimer患者血清中抗Aβ42自身抗体的纯化及鉴定[J].细胞与分子免疫学杂志,2009,25(1):53-54. 被引量:5
  • 4杨志勇,汪华侨,张革,林贤,谢瑶,袁群芳,姚志彬.国人外周血抗β-淀粉样蛋白抗体水平的依龄性变化[J].中山大学学报(医学科学版),2005,26(2):125-128. 被引量:8
  • 5李少兵,汪华侨,林贤,徐杰,姚志彬.接种Aβ_(42)全肽疫苗恒河猴的特异性体液免疫应答[J].细胞与分子免疫学杂志,2005,21(2):202-204. 被引量:6
  • 6Gilda Shayan,Basia Adamiak,Leila H. Choe,Norman Relkin,Kelvin H. Lee.Longitudinal effects of intravenous immunoglobulin on A lzheimer’s cerebrospinal fluid proteome[J]. ELECTROPHORESIS . 2014 (12-13)
  • 7Dennis J. Selkoe.Clearing the Brain’s Amyloid Cobwebs[J]. Neuron . 2001 (2)
  • 8Monica Di Luca,Francesca Colciaghi,Lucia Pastorino,Barbara Borroni,Alessandro Padovani,Flaminio Cattabeni.Platelets as a peripheral district where to study pathogenetic mechanisms of Alzheimer disease: the case of amyloid precursor protein[J]. European Journal of Pharmacology . 2000 (1)
  • 9Shihua Xu,Felicia Gaskin.Increased incidence of anti- β -amyloid autoantibodies secreted by Epstein-Barr virus transformed B cell lines from patients with Alzheimer’s disease[J]. Mechanisms of Ageing and Development . 1997 (1)
  • 10K. Trieb,G. Ransmayr,R. Sgonc,H. Lassmann,B. Grubeck-Loebenstein.APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer’s Disease[J]. Neurobiology of Aging . 1996 (4)

二级参考文献58

  • 1杨志勇,汪华侨,张革,林贤,谢瑶,袁群芳,姚志彬.国人外周血抗β-淀粉样蛋白抗体水平的依龄性变化[J].中山大学学报(医学科学版),2005,26(2):125-128. 被引量:8
  • 2李少兵,汪华侨,林贤,徐杰,姚志彬.接种Aβ_(42)全肽疫苗恒河猴的特异性体液免疫应答[J].细胞与分子免疫学杂志,2005,21(2):202-204. 被引量:6
  • 3Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics [ J ]. Science, 2002, 297 (5580) : 353 - 356.
  • 4Dodel RC, Du Y, Depboylu C, et al. Intravenous irmnunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease[J]. J Neurol Neurosurg Psychiatry, 2004, 75 (10): 1472 - 1474.
  • 5Xu S, Gaskin F. Increased incidence of anti-beta-amyloid autoantibodies secreted by Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease [ J ]. Mech Ageing Dev, 1997, 94 ( 1 - 3) : 213 -222.
  • 6Hyman BT, Smith C, Buldyrev I, et al. Autoantibodies to amyloid-beta and Alzheimer's disease [ J ]. Ann Neurol, 2001, 49 ( 6 ) : 808 - 810.
  • 7Relkin NR, Szabo P, Adamiak B, et al. 18-Month study of intravenous immunoglobulin for treatment of mild Alzheimer disease [ J ]. Neurobiology of Aging, 2008, 21 ( 1 ) : 1 -9.
  • 8Check E. Nerve inflammation halts trial for Alzheimer's drug[J]. Nature, 2002, 415(6871): 462.
  • 9Selkoe DJ. Clearing the brain' s amyloid cobwebs [ J ]. Neuron, 2001, 32(2) : 177 - 180.
  • 10Monsonego A, Maron R, Zota V, et al. Immune hyporesponsiveness to amyloid 13-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease [ J]. Proc Natl Acad Sci USA, 2001,98 (18) : 10273 - 10278.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部